Cargando…

Selective retina therapy for subretinal fluid associated with choroidal nevus

PURPOSE: To report a case of a patient with subretinal fluid (SRF) associated with choroidal nevus (CN), who was treated with selective retina therapy (SRT) and ultimately achieved resolution of the SRF. OBSERVATIONS: A 41-year-old man with SRF associated with CN in his right eye (RE) underwent opht...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Manabu, Miura, Yoko, Kyo, Akika, Hirayama, Kumiko, Kohno, Takeya, Theisen-Kunde, Dirk, Brinkmann, Ralf, Honda, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327275/
https://www.ncbi.nlm.nih.gov/pubmed/32637732
http://dx.doi.org/10.1016/j.ajoc.2020.100794
_version_ 1783552508498542592
author Yamamoto, Manabu
Miura, Yoko
Kyo, Akika
Hirayama, Kumiko
Kohno, Takeya
Theisen-Kunde, Dirk
Brinkmann, Ralf
Honda, Shigeru
author_facet Yamamoto, Manabu
Miura, Yoko
Kyo, Akika
Hirayama, Kumiko
Kohno, Takeya
Theisen-Kunde, Dirk
Brinkmann, Ralf
Honda, Shigeru
author_sort Yamamoto, Manabu
collection PubMed
description PURPOSE: To report a case of a patient with subretinal fluid (SRF) associated with choroidal nevus (CN), who was treated with selective retina therapy (SRT) and ultimately achieved resolution of the SRF. OBSERVATIONS: A 41-year-old man with SRF associated with CN in his right eye (RE) underwent ophthalmologic evaluation, including optic coherence tomography, fluorescein angiography (FA) and indocyanine green angiography. The best corrected visual acuity (BCVA) converted to the logarithm of the minimum angle of resolution (logMAR) was 0.00 in the RE. SRT (532 nm, 1.7 μs pulse duration, 30 pulses in 100Hz; Medical Laser Center Lübeck) was performed with the laser spots equally distributed across the FA leakage area. Until 20 months SRT was repeated several times because the SRF decreased every time in response to SRT, but was not completely resolved and sometimes increased with time. After performing 6 times of SRT session, leakage on FA stopped at 21 months follow-up and SRF was resolved at 31 months. At 60 months after the first SRT, there were no signs of malignant transformation, no SRF, and the BCVA in the RE was 0.22. CONCLUSIONS AND IMPORTANCE: SRT seems to be a useful treatment and proper clinical studies are necessary to establish the best treatment protocol for SRF associated with CN.
format Online
Article
Text
id pubmed-7327275
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73272752020-07-06 Selective retina therapy for subretinal fluid associated with choroidal nevus Yamamoto, Manabu Miura, Yoko Kyo, Akika Hirayama, Kumiko Kohno, Takeya Theisen-Kunde, Dirk Brinkmann, Ralf Honda, Shigeru Am J Ophthalmol Case Rep Case Report PURPOSE: To report a case of a patient with subretinal fluid (SRF) associated with choroidal nevus (CN), who was treated with selective retina therapy (SRT) and ultimately achieved resolution of the SRF. OBSERVATIONS: A 41-year-old man with SRF associated with CN in his right eye (RE) underwent ophthalmologic evaluation, including optic coherence tomography, fluorescein angiography (FA) and indocyanine green angiography. The best corrected visual acuity (BCVA) converted to the logarithm of the minimum angle of resolution (logMAR) was 0.00 in the RE. SRT (532 nm, 1.7 μs pulse duration, 30 pulses in 100Hz; Medical Laser Center Lübeck) was performed with the laser spots equally distributed across the FA leakage area. Until 20 months SRT was repeated several times because the SRF decreased every time in response to SRT, but was not completely resolved and sometimes increased with time. After performing 6 times of SRT session, leakage on FA stopped at 21 months follow-up and SRF was resolved at 31 months. At 60 months after the first SRT, there were no signs of malignant transformation, no SRF, and the BCVA in the RE was 0.22. CONCLUSIONS AND IMPORTANCE: SRT seems to be a useful treatment and proper clinical studies are necessary to establish the best treatment protocol for SRF associated with CN. Elsevier 2020-06-23 /pmc/articles/PMC7327275/ /pubmed/32637732 http://dx.doi.org/10.1016/j.ajoc.2020.100794 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Yamamoto, Manabu
Miura, Yoko
Kyo, Akika
Hirayama, Kumiko
Kohno, Takeya
Theisen-Kunde, Dirk
Brinkmann, Ralf
Honda, Shigeru
Selective retina therapy for subretinal fluid associated with choroidal nevus
title Selective retina therapy for subretinal fluid associated with choroidal nevus
title_full Selective retina therapy for subretinal fluid associated with choroidal nevus
title_fullStr Selective retina therapy for subretinal fluid associated with choroidal nevus
title_full_unstemmed Selective retina therapy for subretinal fluid associated with choroidal nevus
title_short Selective retina therapy for subretinal fluid associated with choroidal nevus
title_sort selective retina therapy for subretinal fluid associated with choroidal nevus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327275/
https://www.ncbi.nlm.nih.gov/pubmed/32637732
http://dx.doi.org/10.1016/j.ajoc.2020.100794
work_keys_str_mv AT yamamotomanabu selectiveretinatherapyforsubretinalfluidassociatedwithchoroidalnevus
AT miurayoko selectiveretinatherapyforsubretinalfluidassociatedwithchoroidalnevus
AT kyoakika selectiveretinatherapyforsubretinalfluidassociatedwithchoroidalnevus
AT hirayamakumiko selectiveretinatherapyforsubretinalfluidassociatedwithchoroidalnevus
AT kohnotakeya selectiveretinatherapyforsubretinalfluidassociatedwithchoroidalnevus
AT theisenkundedirk selectiveretinatherapyforsubretinalfluidassociatedwithchoroidalnevus
AT brinkmannralf selectiveretinatherapyforsubretinalfluidassociatedwithchoroidalnevus
AT hondashigeru selectiveretinatherapyforsubretinalfluidassociatedwithchoroidalnevus